Second, beyond glycemic control, GLP-1 RA exert metabolic and anti-inflammatory effects—such as weight reduction, improved insulin sensitivity, and lowered systemic inflammation—that are particularly relevant in the context of obesity [36]. Here, GLP1R is linked to obesity due to melanocortin 4 receptor deficiency.